The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Next Generation Diabetes Therapy and Drug Delivery-Global Market Insights and Sales Trends 2024

Next Generation Diabetes Therapy and Drug Delivery-Global Market Insights and Sales Trends 2024

Publishing Date : Nov, 2023

License Type :
 

Report Code : 1838865

No of Pages : 110

Ask Your Query

Synopsis

Next generation diabetic therapy and drug delivery systems are used to improve the adherence to insulin in diabetic patients to reduce the risk of complications related to sudden change in the blood sugar level.

The global Next Generation Diabetes Therapy and Drug Delivery market size is expected to reach US$ 7852.9 million by 2029, growing at a CAGR of 23.3% from 2023 to 2029. The market is mainly driven by the significant applications of Next Generation Diabetes Therapy and Drug Delivery in various end use industries. The expanding demands from the Diagnostic/Clinics, ICUs and Home Healthcare,, are propelling Next Generation Diabetes Therapy and Drug Delivery market. Inhalable Insulin, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Oral Insulin segment is estimated at % CAGR for the next seven-year period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Next Generation Diabetes Therapy and Drug Delivery, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Next Generation Diabetes Therapy and Drug Delivery market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Next Generation Diabetes Therapy and Drug Delivery market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Next Generation Diabetes Therapy and Drug Delivery sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Next Generation Diabetes Therapy and Drug Delivery covered in this report include Johnson & Johnson, Abbott Laboratories, Medtronic, Sanofi, Novo Nordisk, MannKind Corporation, Enteris BioPharma, Dexcom and Senseonics, etc.

The global Next Generation Diabetes Therapy and Drug Delivery market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

  • Johnson & Johnson
  • Abbott Laboratories
  • Medtronic
  • Sanofi
  • Novo Nordisk
  • MannKind Corporation
  • Enteris BioPharma
  • Dexcom
  • Senseonics
  • Medtech
  • Synertech
  • Zosano Pharma
  • Relmada Therapeutics
  • Eli Lilly and Company
  • Transdermal Specialties

Global Next Generation Diabetes Therapy and Drug Delivery market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Next Generation Diabetes Therapy and Drug Delivery market, Segment by Type:

  • Inhalable Insulin
  • Oral Insulin
  • Insulin Patches
  • CGM Systems
  • Artificial Pancreas

Global Next Generation Diabetes Therapy and Drug Delivery market, by Application

  • Diagnostic/Clinics
  • ICUs
  • Home Healthcare

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Next Generation Diabetes Therapy and Drug Delivery companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

Index

1 Market Overview of Next Generation Diabetes Therapy and Drug Delivery
1.1 Next Generation Diabetes Therapy and Drug Delivery Market Overview
1.1.1 Next Generation Diabetes Therapy and Drug Delivery Product Scope
1.1.2 Next Generation Diabetes Therapy and Drug Delivery Market Status and Outlook
1.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Region (2018-2029)
1.4 Global Next Generation Diabetes Therapy and Drug Delivery Historic Market Size by Region (2018-2023)
1.5 Global Next Generation Diabetes Therapy and Drug Delivery Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Next Generation Diabetes Therapy and Drug Delivery Market Size (2018-2029)
1.6.1 North America Next Generation Diabetes Therapy and Drug Delivery Market Size (2018-2029)
1.6.2 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size (2018-2029)
1.6.3 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size (2018-2029)
1.6.4 Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size (2018-2029)
1.6.5 Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Size (2018-2029)
2 Next Generation Diabetes Therapy and Drug Delivery Market by Type
2.1 Introduction
2.1.1 Inhalable Insulin
2.1.2 Oral Insulin
2.1.3 Insulin Patches
2.1.4 CGM Systems
2.1.5 Artificial Pancreas
2.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Next Generation Diabetes Therapy and Drug Delivery Historic Market Size by Type (2018-2023)
2.2.2 Global Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Next Generation Diabetes Therapy and Drug Delivery Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Next Generation Diabetes Therapy and Drug Delivery Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Next Generation Diabetes Therapy and Drug Delivery Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue Breakdown by Type (2018-2029)
3 Next Generation Diabetes Therapy and Drug Delivery Market Overview by Application
3.1 Introduction
3.1.1 Diagnostic/Clinics
3.1.2 ICUs
3.1.3 Home Healthcare
3.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Next Generation Diabetes Therapy and Drug Delivery Historic Market Size by Application (2018-2023)
3.2.2 Global Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Next Generation Diabetes Therapy and Drug Delivery Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Next Generation Diabetes Therapy and Drug Delivery Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Next Generation Diabetes Therapy and Drug Delivery Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Revenue Breakdown by Application (2018-2029)
4 Next Generation Diabetes Therapy and Drug Delivery Competition Analysis by Players
4.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Next Generation Diabetes Therapy and Drug Delivery as of 2022)
4.3 Date of Key Players Enter into Next Generation Diabetes Therapy and Drug Delivery Market
4.4 Global Top Players Next Generation Diabetes Therapy and Drug Delivery Headquarters and Area Served
4.5 Key Players Next Generation Diabetes Therapy and Drug Delivery Product Solution and Service
4.6 Competitive Status
4.6.1 Next Generation Diabetes Therapy and Drug Delivery Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Johnson & Johnson
5.1.1 Johnson & Johnson Profile
5.1.2 Johnson & Johnson Main Business
5.1.3 Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Products, Services and Solutions
5.1.4 Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Revenue (US$ Million) & (2018-2023)
5.1.5 Johnson & Johnson Recent Developments
5.2 Abbott Laboratories
5.2.1 Abbott Laboratories Profile
5.2.2 Abbott Laboratories Main Business
5.2.3 Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Products, Services and Solutions
5.2.4 Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Revenue (US$ Million) & (2018-2023)
5.2.5 Abbott Laboratories Recent Developments
5.3 Medtronic
5.3.1 Medtronic Profile
5.3.2 Medtronic Main Business
5.3.3 Medtronic Next Generation Diabetes Therapy and Drug Delivery Products, Services and Solutions
5.3.4 Medtronic Next Generation Diabetes Therapy and Drug Delivery Revenue (US$ Million) & (2018-2023)
5.3.5 Sanofi Recent Developments
5.4 Sanofi
5.4.1 Sanofi Profile
5.4.2 Sanofi Main Business
5.4.3 Sanofi Next Generation Diabetes Therapy and Drug Delivery Products, Services and Solutions
5.4.4 Sanofi Next Generation Diabetes Therapy and Drug Delivery Revenue (US$ Million) & (2018-2023)
5.4.5 Sanofi Recent Developments
5.5 Novo Nordisk
5.5.1 Novo Nordisk Profile
5.5.2 Novo Nordisk Main Business
5.5.3 Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Products, Services and Solutions
5.5.4 Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Revenue (US$ Million) & (2018-2023)
5.5.5 Novo Nordisk Recent Developments
5.6 MannKind Corporation
5.6.1 MannKind Corporation Profile
5.6.2 MannKind Corporation Main Business
5.6.3 MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Products, Services and Solutions
5.6.4 MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Revenue (US$ Million) & (2018-2023)
5.6.5 MannKind Corporation Recent Developments
5.7 Enteris BioPharma
5.7.1 Enteris BioPharma Profile
5.7.2 Enteris BioPharma Main Business
5.7.3 Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Products, Services and Solutions
5.7.4 Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Revenue (US$ Million) & (2018-2023)
5.7.5 Enteris BioPharma Recent Developments
5.8 Dexcom
5.8.1 Dexcom Profile
5.8.2 Dexcom Main Business
5.8.3 Dexcom Next Generation Diabetes Therapy and Drug Delivery Products, Services and Solutions
5.8.4 Dexcom Next Generation Diabetes Therapy and Drug Delivery Revenue (US$ Million) & (2018-2023)
5.8.5 Dexcom Recent Developments
5.9 Senseonics
5.9.1 Senseonics Profile
5.9.2 Senseonics Main Business
5.9.3 Senseonics Next Generation Diabetes Therapy and Drug Delivery Products, Services and Solutions
5.9.4 Senseonics Next Generation Diabetes Therapy and Drug Delivery Revenue (US$ Million) & (2018-2023)
5.9.5 Senseonics Recent Developments
5.10 Medtech
5.10.1 Medtech Profile
5.10.2 Medtech Main Business
5.10.3 Medtech Next Generation Diabetes Therapy and Drug Delivery Products, Services and Solutions
5.10.4 Medtech Next Generation Diabetes Therapy and Drug Delivery Revenue (US$ Million) & (2018-2023)
5.10.5 Medtech Recent Developments
5.11 Synertech
5.11.1 Synertech Profile
5.11.2 Synertech Main Business
5.11.3 Synertech Next Generation Diabetes Therapy and Drug Delivery Products, Services and Solutions
5.11.4 Synertech Next Generation Diabetes Therapy and Drug Delivery Revenue (US$ Million) & (2018-2023)
5.11.5 Synertech Recent Developments
5.12 Zosano Pharma
5.12.1 Zosano Pharma Profile
5.12.2 Zosano Pharma Main Business
5.12.3 Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Products, Services and Solutions
5.12.4 Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Revenue (US$ Million) & (2018-2023)
5.12.5 Zosano Pharma Recent Developments
5.13 Relmada Therapeutics
5.13.1 Relmada Therapeutics Profile
5.13.2 Relmada Therapeutics Main Business
5.13.3 Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Products, Services and Solutions
5.13.4 Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Revenue (US$ Million) & (2018-2023)
5.13.5 Relmada Therapeutics Recent Developments
5.14 Eli Lilly and Company
5.14.1 Eli Lilly and Company Profile
5.14.2 Eli Lilly and Company Main Business
5.14.3 Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Products, Services and Solutions
5.14.4 Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Revenue (US$ Million) & (2018-2023)
5.14.5 Eli Lilly and Company Recent Developments
5.15 Transdermal Specialties
5.15.1 Transdermal Specialties Profile
5.15.2 Transdermal Specialties Main Business
5.15.3 Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Products, Services and Solutions
5.15.4 Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Revenue (US$ Million) & (2018-2023)
5.15.5 Transdermal Specialties Recent Developments
6 North America
6.1 North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Next Generation Diabetes Therapy and Drug Delivery Market Dynamics
11.1 Next Generation Diabetes Therapy and Drug Delivery Industry Trends
11.2 Next Generation Diabetes Therapy and Drug Delivery Market Drivers
11.3 Next Generation Diabetes Therapy and Drug Delivery Market Challenges
11.4 Next Generation Diabetes Therapy and Drug Delivery Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock